View ValuationSobute New Materials 将来の成長Future 基準チェック /46Sobute New Materials利益と収益がそれぞれ年間28.3%と16.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に5.8% 27.8%なると予測されています。主要情報28.3%収益成長率27.84%EPS成長率Chemicals 収益成長30.0%収益成長率16.3%将来の株主資本利益率5.79%アナリストカバレッジLow最終更新日23 Apr 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesDeclared Dividend • May 30Dividend increased to CN¥0.12Dividend of CN¥0.12 is 20% higher than last year. Ex-date: 3rd June 2026 Payment date: 3rd June 2026 Dividend yield will be 0.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (40% earnings payout ratio) and cash flows (19% cash payout ratio). The dividend has decreased over the past 86 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 109% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Board Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Qijun Yu was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.お知らせ • Apr 16Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu Chinaお知らせ • Mar 30Sobute New Materials Co., Ltd to Report Q1, 2026 Results on Apr 28, 2026Sobute New Materials Co., Ltd announced that they will report Q1, 2026 results on Apr 28, 2026お知らせ • Dec 26Sobute New Materials Co., Ltd to Report Fiscal Year 2025 Results on Apr 16, 2026Sobute New Materials Co., Ltd announced that they will report fiscal year 2025 results on Apr 16, 2026お知らせ • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2025 Results on Oct 29, 2025Sobute New Materials Co., Ltd announced that they will report Q3, 2025 results on Oct 29, 2025お知らせ • Jun 30Sobute New Materials Co., Ltd to Report First Half, 2025 Results on Aug 29, 2025Sobute New Materials Co., Ltd announced that they will report first half, 2025 results on Aug 29, 2025お知らせ • Apr 29Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025, at 09:30 China Standard Time.お知らせ • Mar 28Sobute New Materials Co., Ltd to Report Q1, 2025 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report Q1, 2025 results on Apr 29, 2025お知らせ • Dec 27Sobute New Materials Co., Ltd to Report Fiscal Year 2024 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report fiscal year 2024 results on Apr 29, 2025Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.11 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.11 in 3Q 2023). Revenue: CN¥912.4m (flat on 3Q 2023). Net income: CN¥25.3m (down 43% from 3Q 2023). Profit margin: 2.8% (down from 4.9% in 3Q 2023). Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 23% per year, which means it has not declined as severely as earnings.お知らせ • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2024 Results on Oct 26, 2024Sobute New Materials Co., Ltd announced that they will report Q3, 2024 results on Oct 26, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥7.57, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.Reported Earnings • Aug 27Second quarter 2024 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.069 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥984.5m (down 1.0% from 2Q 2023). Net income: CN¥32.2m (down 43% from 2Q 2023). Profit margin: 3.3% (down from 5.7% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.お知らせ • Jun 28Sobute New Materials Co., Ltd to Report First Half, 2024 Results on Aug 27, 2024Sobute New Materials Co., Ltd announced that they will report first half, 2024 results on Aug 27, 2024Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥9.48, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.お知らせ • Apr 28Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu ChinaReported Earnings • Apr 27First quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.10 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.05 (down from CN¥0.10 in 1Q 2023). Revenue: CN¥578.6m (down 13% from 1Q 2023). Net income: CN¥21.1m (down 48% from 1Q 2023). Profit margin: 3.6% (down from 6.1% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.お知らせ • Mar 29Sobute New Materials Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report Q1, 2024 results on Apr 26, 2024Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥7.94, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 62% over the past three years.New Risk • Jan 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (109% cash payout ratio). Profit margins are more than 30% lower than last year (5.4% net profit margin). Shareholders have been diluted in the past year (3.0% increase in shares outstanding).お知らせ • Dec 30Sobute New Materials Co., Ltd to Report Fiscal Year 2023 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report fiscal year 2023 results on Apr 26, 2024Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.17 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.11 (down from CN¥0.17 in 3Q 2022). Revenue: CN¥915.6m (down 5.1% from 3Q 2022). Net income: CN¥44.5m (down 38% from 3Q 2022). Profit margin: 4.9% (down from 7.4% in 3Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.20 in 2Q 2022). Revenue: CN¥994.9m (down 3.7% from 2Q 2022). Net income: CN¥56.6m (down 33% from 2Q 2022). Profit margin: 5.7% (down from 8.1% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Reported Earnings • Apr 23Full year 2022 earnings released: EPS: CN¥0.69 (vs CN¥1.27 in FY 2021)Full year 2022 results: EPS: CN¥0.69 (down from CN¥1.27 in FY 2021). Revenue: CN¥3.71b (down 18% from FY 2021). Net income: CN¥287.9m (down 46% from FY 2021). Profit margin: 7.8% (down from 12% in FY 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥18.41, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 8.9% over the past year.Board Change • Nov 16Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Employees Representative Member of the Supervisory Board Hua Li is the most experienced director on the board, commencing their role in 2021. Independent Director Lily Li was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.Reported Earnings • Oct 27Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.36 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.36 in 3Q 2021). Revenue: CN¥965.3m (down 19% from 3Q 2021). Net income: CN¥71.4m (down 53% from 3Q 2021). Profit margin: 7.4% (down from 13% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.33 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.20 (down from CN¥0.33 in 2Q 2021). Revenue: CN¥1.03b (down 19% from 2Q 2021). Net income: CN¥83.9m (down 39% from 2Q 2021). Profit margin: 8.1% (down from 11% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 38%, compared to a 40% growth forecast for the Chemicals industry in China.Reported Earnings • Apr 30First quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.18 in 1Q 2021). Revenue: CN¥716.2m (down 7.3% from 1Q 2021). Net income: CN¥80.2m (up 2.8% from 1Q 2021). Profit margin: 11% (up from 10% in 1Q 2021). The increase in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.Reported Earnings • Apr 17Full year 2021 earnings released: EPS: CN¥1.27 (vs CN¥1.16 in FY 2020)Full year 2021 results: EPS: CN¥1.27 (up from CN¥1.16 in FY 2020). Revenue: CN¥4.52b (up 24% from FY 2020). Net income: CN¥532.8m (up 21% from FY 2020). Profit margin: 12% (in line with FY 2020). Over the next year, revenue is forecast to grow 25%, compared to a 50% growth forecast for the industry in China.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥25.19, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 35% over the past year.Valuation Update With 7 Day Price Move • Nov 20Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥21.95, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China.Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.36 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥1.19b (up 16% from 3Q 2020). Net income: CN¥151.0m (up 11% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020).Reported Earnings • Aug 19Second quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.32 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.27b (up 27% from 2Q 2020). Net income: CN¥137.8m (up 17% from 2Q 2020). Profit margin: 11% (in line with 2Q 2020).Reported Earnings • Apr 26First quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.16 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥772.4m (up 82% from 1Q 2020). Net income: CN¥78.1m (up 58% from 1Q 2020). Profit margin: 10% (down from 12% in 1Q 2020). The decrease in margin was driven by higher expenses.Reported Earnings • Mar 27Full year 2020 earnings released: EPS CN¥1.39 (vs CN¥1.14 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥3.65b (up 11% from FY 2019). Net income: CN¥440.8m (up 24% from FY 2019). Profit margin: 12% (up from 11% in FY 2019). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥27.30, the stock is trading at a trailing P/E ratio of 21x, up from the previous P/E ratio of 17.9x. This compares to an average P/E of 35x in the Chemicals industry in China.Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥26.62, the stock is trading at a trailing P/E ratio of 20.5x, up from the previous P/E ratio of 17.7x. This compares to an average P/E of 36x in the Chemicals industry in China.業績と収益の成長予測XSSC:603916 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20285,617279N/A493112/31/20274,849219N/A359112/31/20264,140162N/A30613/31/20263,570127273432N/A12/31/20253,556121164371N/A9/30/20253,657111342545N/A6/30/20253,665106214474N/A3/31/20253,65899349632N/A12/31/20243,55596334581N/A9/30/20243,48298125423N/A6/30/20243,485117338606N/A3/31/20243,495141-6294N/A12/31/20233,58216032370N/A9/30/20233,576194119437N/A6/30/20233,626221-126212N/A3/31/20233,66424837381N/A12/31/20223,715288-78219N/A9/30/20224,004401-136169N/A6/30/20224,224481-3311N/A3/31/20224,466535-43242N/A12/31/20214,52253339336N/A9/30/20214,434505-279168N/A6/30/20214,268490-260130N/A3/31/20213,999470-41336N/A12/31/20203,652441-14333N/A9/30/20203,456406273482N/A6/30/20203,348387215396N/A3/31/20203,264355260432N/A12/31/20193,307354N/A419N/A9/30/20193,017297N/A144N/A6/30/20192,750228N/A3N/A3/31/20192,427287N/A-13N/A12/31/20182,316268N/A-98N/A9/30/20182,100241N/A-255N/A6/30/20181,912239N/A-157N/A3/31/20181,773129N/A-185N/A12/31/20171,680134N/A-121N/A9/30/20171,553154N/A161N/A6/30/20171,450147N/A179N/A3/31/20171,284140N/A169N/A12/31/20161,314133N/A155N/A6/30/20161,259145N/A50N/A3/31/20161,287158N/A63N/A12/31/20151,314171N/A75N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 603916の予測収益成長率 (年間28.3% ) は 貯蓄率 ( 2.4% ) を上回っています。収益対市場: 603916の収益 ( 28.3% ) はCN市場 ( 27.1% ) よりも速いペースで成長すると予測されています。高成長収益: 603916の収益は今後 3 年間で 大幅に 増加すると予想されています。収益対市場: 603916の収益 ( 16.3% ) CN市場 ( 16.4% ) よりも速いペースで成長すると予測されています。高い収益成長: 603916の収益 ( 16.3% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 603916の 自己資本利益率 は、3年後には低くなると予測されています ( 5.8 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/03 16:28終値2026/06/03 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sobute New Materials Co., Ltd 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。5 アナリスト機関Maoda YangChina International Capital Corporation LimitedWei LiuHaitong International Research LimitedYanhe FangHuatai Research2 その他のアナリストを表示
Declared Dividend • May 30Dividend increased to CN¥0.12Dividend of CN¥0.12 is 20% higher than last year. Ex-date: 3rd June 2026 Payment date: 3rd June 2026 Dividend yield will be 0.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (40% earnings payout ratio) and cash flows (19% cash payout ratio). The dividend has decreased over the past 86 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 109% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Board Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Qijun Yu was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
お知らせ • Apr 16Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China
お知らせ • Mar 30Sobute New Materials Co., Ltd to Report Q1, 2026 Results on Apr 28, 2026Sobute New Materials Co., Ltd announced that they will report Q1, 2026 results on Apr 28, 2026
お知らせ • Dec 26Sobute New Materials Co., Ltd to Report Fiscal Year 2025 Results on Apr 16, 2026Sobute New Materials Co., Ltd announced that they will report fiscal year 2025 results on Apr 16, 2026
お知らせ • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2025 Results on Oct 29, 2025Sobute New Materials Co., Ltd announced that they will report Q3, 2025 results on Oct 29, 2025
お知らせ • Jun 30Sobute New Materials Co., Ltd to Report First Half, 2025 Results on Aug 29, 2025Sobute New Materials Co., Ltd announced that they will report first half, 2025 results on Aug 29, 2025
お知らせ • Apr 29Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025, at 09:30 China Standard Time.
お知らせ • Mar 28Sobute New Materials Co., Ltd to Report Q1, 2025 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report Q1, 2025 results on Apr 29, 2025
お知らせ • Dec 27Sobute New Materials Co., Ltd to Report Fiscal Year 2024 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report fiscal year 2024 results on Apr 29, 2025
Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.11 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.11 in 3Q 2023). Revenue: CN¥912.4m (flat on 3Q 2023). Net income: CN¥25.3m (down 43% from 3Q 2023). Profit margin: 2.8% (down from 4.9% in 3Q 2023). Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 23% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2024 Results on Oct 26, 2024Sobute New Materials Co., Ltd announced that they will report Q3, 2024 results on Oct 26, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥7.57, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.
Reported Earnings • Aug 27Second quarter 2024 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.069 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥984.5m (down 1.0% from 2Q 2023). Net income: CN¥32.2m (down 43% from 2Q 2023). Profit margin: 3.3% (down from 5.7% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 28Sobute New Materials Co., Ltd to Report First Half, 2024 Results on Aug 27, 2024Sobute New Materials Co., Ltd announced that they will report first half, 2024 results on Aug 27, 2024
Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥9.48, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.
お知らせ • Apr 28Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China
Reported Earnings • Apr 27First quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.10 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.05 (down from CN¥0.10 in 1Q 2023). Revenue: CN¥578.6m (down 13% from 1Q 2023). Net income: CN¥21.1m (down 48% from 1Q 2023). Profit margin: 3.6% (down from 6.1% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 29Sobute New Materials Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report Q1, 2024 results on Apr 26, 2024
Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥7.94, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 62% over the past three years.
New Risk • Jan 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (109% cash payout ratio). Profit margins are more than 30% lower than last year (5.4% net profit margin). Shareholders have been diluted in the past year (3.0% increase in shares outstanding).
お知らせ • Dec 30Sobute New Materials Co., Ltd to Report Fiscal Year 2023 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report fiscal year 2023 results on Apr 26, 2024
Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.17 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.11 (down from CN¥0.17 in 3Q 2022). Revenue: CN¥915.6m (down 5.1% from 3Q 2022). Net income: CN¥44.5m (down 38% from 3Q 2022). Profit margin: 4.9% (down from 7.4% in 3Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.20 in 2Q 2022). Revenue: CN¥994.9m (down 3.7% from 2Q 2022). Net income: CN¥56.6m (down 33% from 2Q 2022). Profit margin: 5.7% (down from 8.1% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Reported Earnings • Apr 23Full year 2022 earnings released: EPS: CN¥0.69 (vs CN¥1.27 in FY 2021)Full year 2022 results: EPS: CN¥0.69 (down from CN¥1.27 in FY 2021). Revenue: CN¥3.71b (down 18% from FY 2021). Net income: CN¥287.9m (down 46% from FY 2021). Profit margin: 7.8% (down from 12% in FY 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥18.41, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 8.9% over the past year.
Board Change • Nov 16Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Employees Representative Member of the Supervisory Board Hua Li is the most experienced director on the board, commencing their role in 2021. Independent Director Lily Li was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
Reported Earnings • Oct 27Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.36 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.36 in 3Q 2021). Revenue: CN¥965.3m (down 19% from 3Q 2021). Net income: CN¥71.4m (down 53% from 3Q 2021). Profit margin: 7.4% (down from 13% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.33 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.20 (down from CN¥0.33 in 2Q 2021). Revenue: CN¥1.03b (down 19% from 2Q 2021). Net income: CN¥83.9m (down 39% from 2Q 2021). Profit margin: 8.1% (down from 11% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 38%, compared to a 40% growth forecast for the Chemicals industry in China.
Reported Earnings • Apr 30First quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.18 in 1Q 2021). Revenue: CN¥716.2m (down 7.3% from 1Q 2021). Net income: CN¥80.2m (up 2.8% from 1Q 2021). Profit margin: 11% (up from 10% in 1Q 2021). The increase in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.
Reported Earnings • Apr 17Full year 2021 earnings released: EPS: CN¥1.27 (vs CN¥1.16 in FY 2020)Full year 2021 results: EPS: CN¥1.27 (up from CN¥1.16 in FY 2020). Revenue: CN¥4.52b (up 24% from FY 2020). Net income: CN¥532.8m (up 21% from FY 2020). Profit margin: 12% (in line with FY 2020). Over the next year, revenue is forecast to grow 25%, compared to a 50% growth forecast for the industry in China.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥25.19, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 35% over the past year.
Valuation Update With 7 Day Price Move • Nov 20Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥21.95, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China.
Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.36 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥1.19b (up 16% from 3Q 2020). Net income: CN¥151.0m (up 11% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020).
Reported Earnings • Aug 19Second quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.32 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.27b (up 27% from 2Q 2020). Net income: CN¥137.8m (up 17% from 2Q 2020). Profit margin: 11% (in line with 2Q 2020).
Reported Earnings • Apr 26First quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.16 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥772.4m (up 82% from 1Q 2020). Net income: CN¥78.1m (up 58% from 1Q 2020). Profit margin: 10% (down from 12% in 1Q 2020). The decrease in margin was driven by higher expenses.
Reported Earnings • Mar 27Full year 2020 earnings released: EPS CN¥1.39 (vs CN¥1.14 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥3.65b (up 11% from FY 2019). Net income: CN¥440.8m (up 24% from FY 2019). Profit margin: 12% (up from 11% in FY 2019). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥27.30, the stock is trading at a trailing P/E ratio of 21x, up from the previous P/E ratio of 17.9x. This compares to an average P/E of 35x in the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥26.62, the stock is trading at a trailing P/E ratio of 20.5x, up from the previous P/E ratio of 17.7x. This compares to an average P/E of 36x in the Chemicals industry in China.